PATENT CLAIM ANALYSIS

Application Number: 15744734
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["424", "133100"]

Abstract:
Provided are anti-GM-CSF antibodies or fragments thereof including humanized antibodies and fragments. Also provided are uses of the antibodies and fragments for therapeutic, diagnostic and prognostic purposes. Therapeutic uses of the antibodies and fragments, for example include the treatment of inflammatory and autoimmune diseases and disorders.

Claim (Index 24):
The method of  claim 23 , wherein the cancer is selected from the group consisting of bladder cancer, breast cancer, colorectal cancer, endometrial cancer, esophageal cancer, head and neck cancer, kidney cancer, leukemia, liver cancer, lung cancer, lymphoma, melanoma, pancreatic cancer, prostate cancer, and thyroid cancer.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 86.0
- Lexical Diversity: 1.7
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11918368', '14718923', '12681396', '12766444', '13988498']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8027230156366048
- 35 USC 102 Novelty (BERT): 0.5353016610598159
- Combined Prediction Score: 0.7759808801789259
- Mean Citation Score: 373.708054
- Max Citation Score: 386.97614
- Similarity Product: 252.50415856195687

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test